Oramed Pharmaceuticals

Performance

About Oramed Pharmaceuticals

Oramed Pharmaceuticals is a biopharmaceutical company focused on developing oral drug delivery solutions, notably an oral insulin capsule that aims to transform diabetes care by enabling insulin therapy without injections. The company markets and advances its pipeline globally, with emphasis on oral insulin (ORMD-0801) and other oral peptide therapies designed to improve patient compliance and broaden treatment options for diabetes and related metabolic conditions. Headquartered in the United States, Oramed actively engages in research, development, and investor relations while highlighting benefits of noninvasive administration and reduced infection risk. The organization emphasizes patient-friendly, needle-free approaches to insulin therapy and other oral biologics.